ArticleDrugs - real world outcomes2025

Comparative Efficacy of Lenvatinib Plus Immunotherapy and Regorafenib Plus Immunotherapy After Lenvatinib Failure for Advanced Hepatocellular Carcinoma: A Retrospective Study.

Zeyu Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.